Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell...

Area of Science:

• Immunology
• Virology
• Cell Biology

Background:

• Dendritic cells (DCs) are crucial for initiating and regulating virus-specific immune responses.
• Hepatitis C virus (HCV) infection can lead to chronic disease, characterized by impaired immune control.
• The role of peripheral blood dendritic cells (PBDCs) in the persistence of HCV infection requires further investigation.

Purpose of the Study:

• To investigate the characteristics of PBDCs in patients with chronic hepatitis C (CHC).
• To compare PBDCs in CHC patients with those in healthy seronegative (HSN) individuals and those who spontaneously resolved HCV infection (HSP).
• To evaluate the relationship between PBDC function and HCV-specific CD4(+) T-cell reactivity.

Main Methods:

• Flow cytometry was used to analyze the number, immunophenotype, and cytokine expression (IL-12, IL-10) of PBDCs in whole-blood samples.
• Peripheral blood mononuclear cells (PBMCs) were stimulated in vitro with HCV peptides to assess HCV-specific CD4(+) T-cell activation, proliferation, and cytokine production.

Main Results:

• PBDCs were numerically reduced in CHC patients compared to HSN controls.
• PBDCs from CHC patients exhibited lower interleukin-12 (IL-12) and higher interleukin-10 (IL-10) expression than those from HSN controls.
• HSP subjects had PBDC profiles similar to HSN controls, and HCV-specific CD4(+) T-cell proliferation was impaired in CHC patients, correlating inversely with IL-10 and directly with PBDC number and IL-12 production.

Conclusions:

• Altered PBDC numbers and cytokine profiles (reduced IL-12, increased IL-10) in CHC patients contribute to the dysregulation of HCV-specific immunity.
• PBDCs may serve as a potential non-invasive biomarker for immune monitoring in patients with chronic hepatitis C.